Trials / Conditions / Peripheral T Cells Lymphoma (PTCL)
Peripheral T Cells Lymphoma (PTCL)
4 registered clinical trials studyying Peripheral T Cells Lymphoma (PTCL) — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL NCT07372352 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Not Yet Recruiting | Linperlisib Combined With Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma NCT07139353 | Sun Yat-sen University | Phase 1 / Phase 2 |
| Recruiting | A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas NCT07018752 | The Lymphoma Academic Research Organisation | Phase 1 / Phase 2 |
| Recruiting | Polyspecific Antibodies in Lymphoproliferative T-cell Disorders NCT06495723 | Xenothera SAS | Phase 1 / Phase 2 |